Loading organizations...
Groupe SFPI SA operates as a diversified industrial group, manufacturing and distributing a comprehensive range of equipment primarily for the construction and manufacturing sectors. The company's offerings span various essential applications, including industrial locking solutions and specialized equipment designed for the safety of property and individuals. Through its segments, SFPI develops robust technical solutions tailored to meet the exacting demands of industrial and building environments across Europe and internationally.
The company's origins trace back to 1983 with an initial acquisition, though Groupe SFPI was formally established in 1985 as a holding company by Henri Morel, an HEC graduate. Morel, alongside other entrepreneurs, founded the group with the strategic insight to aggregate and develop profitable, niche industrial companies. This foundation was built on recovering and growing industrial firms, consolidating their market presence and expanding their reach in specialized equipment manufacturing.
SFPI's diverse product portfolio serves a broad customer base within the construction, manufacturing, and safety industries. The group's vision centers on its continued role as a significant European industrial player, designing, producing, and distributing essential equipment. It remains committed to supporting these critical sectors by providing reliable and adaptable solutions, ensuring the protection and functionality required by its industrial and building clients globally.
SFPI has 5 tracked investments across 4 companies. The latest tracked deal is $4.1M Series B Extension in Synergia Medical in January 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 18, 2023 | Synergia Medical | $4.1M Series B Extension | — | Jacques Berrebi, Invest.bw, Investsud, Newton Biocapital, Sriw, Theclubdeal |
| Mar 1, 2020 | ITeos Therapeutics | $130.0M Series B | Aaron Davis, Derek Dirocco | 6 Dimensions Capital, Curative Ventures, Fund+, HBM Partners, Invus, Janus Henderson Investors, MPM Capital, RTW Investments, Sriw, Vives Louvain Technology Fund |
| Sep 26, 2018 | Minoryx Therapeutics | $25.1M Series B | Philippe Monteyne | Caixa Capital Risc, Chiesi Ventures, Healthequity, Idinvest Partners, Kurma Partners, Roche, Sambrinvest, Gery Lefebvre, Ysios Capital |
| Sep 4, 2018 | Miracor Medical SA | $34.8M Series D | Ming Capital | Noshaq, Quest For Growth |
| Jun 1, 2018 | ITeos Therapeutics | $75.0M Series B | MPM Capital | Atlas Venture, Hakan Goker, RA Capital, 6 Dimensions Capital, Curative Ventures, Fund+, Priyanka Belawat, Sriw, Vives Louvain Technology Fund |